Alessandra Sottini
Overview
Explore the profile of Alessandra Sottini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
3693
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Natali P, Piantelli M, Sottini A, Eufemi M, Banfi C, Imberti L
Front Nutr
. 2025 Feb;
12:1519905.
PMID: 39980679
Nutritional interventions facilitating the consumption of natural, affordable, and environment-compatible health-promoting functional foods are a promising strategy for controlling non-communicable diseases. Given that the complex of tomato micronutrients produces healthier...
2.
Snyder T, Gittelman R, Klinger M, May D, Osborne E, Taniguchi R, et al.
Front Immunol
. 2025 Jan;
15():1488860.
PMID: 39840037
Introduction: T cells are involved in the early identification and clearance of viral infections and also support the development of antibodies by B cells. This central role for T cells...
3.
Borlenghi E, Zollner T, Rossi G, Pagani C, Cattaneo C, Malagola M, et al.
Mediterr J Hematol Infect Dis
. 2024 Nov;
16(1):e2024080.
PMID: 39534710
No abstract available.
4.
Quiros-Roldan E, Sottini A, Natali P, Imberti L
Microorganisms
. 2024 Apr;
12(4).
PMID: 38674719
Immune system aging is becoming a field of increasing public health interest because of prolonged life expectancy, which is not paralleled by an increase in health expectancy. As age progresses,...
5.
Delmonte O, Oguz C, Dobbs K, Myint-Hpu K, Palterer B, Abers M, et al.
J Allergy Clin Immunol
. 2023 Dec;
153(6):1655-1667.
PMID: 38154666
Background: Functional T-cell responses are essential for virus clearance and long-term protection after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, whereas certain clinical factors, such as older age and...
6.
Imberti L, Magro P, Sottini A, Quaresima V, Castelli F, Quiros-Roldan E
Immun Inflamm Dis
. 2023 Nov;
11(11):e1056.
PMID: 38018592
Background: Auto-antibodies neutralizing the activity of type I interferons have been recently described in patients infected by SARS-CoV-2. They can be present even before the onset of the infection. Since...
7.
Sottini A, Quaresima V, Barbaro M, Moiola L, Filippi M, Malentacchi M, et al.
J Neuroimmunol
. 2023 Aug;
382:578170.
PMID: 37579546
Thymic and bone marrow outputs were evaluated in 13 sequential samples of 68 multiple sclerosis patients who initiated alemtuzumab and were clinically followed for 48 months. Three months after alemtuzumab...
8.
Quiros-Roldan E, Sottini A, Signorini S, Serana F, Tiecco G, Imberti L
Viruses
. 2023 May;
15(5).
PMID: 37243300
Anti-cytokine autoantibodies and, in particular, anti-type I interferons are increasingly described in association with immunodeficient, autoimmune, and immune-dysregulated conditions. Their presence in otherwise healthy individuals may result in a phenotype...
9.
Wang L, Candia J, Ma L, Zhao Y, Imberti L, Sottini A, et al.
Int J Biol Sci
. 2022 Oct;
18(15):5591-5606.
PMID: 36263161
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the pandemic respiratory infectious disease COVID-19. However, clinical manifestations and outcomes differ significantly among COVID-19 patients, ranging from asymptomatic to...
10.
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Bastard P, Vazquez S, Liu J, Laurie M, Wang C, Gervais A, et al.
Sci Immunol
. 2022 Jul;
8(90):eabp8966.
PMID: 35857576
Life-threatening "breakthrough" cases of critical COVID-19 are attributed to poor or waning antibody (Ab) response to SARS-CoV-2 vaccines in individuals already at risk. Preexisting auto-Abs neutralizing type I IFNs underlie...